Join        Login             Stock Quote

AmerisourceBergen Authorizes a New $750 Million Share Repurchase Program and Approves Quarterly Dividend

Thursday, May 10, 2012 9:05 AM

The Board of Directors of AmerisourceBergen Corporation (NYSE: ABC) today authorized a new $750 million share repurchase program, effective immediately. The Company has completed its previous $750 million share repurchase program, which was authorized on August 11, 2011. AmerisourceBergen expects to use the new program to repurchase its outstanding shares of common stock, subject to market conditions. To date in fiscal year 2012, which ends September 30, 2012, the Company has spent $500.0 million to repurchase its outstanding shares of common stock.

“Our $500 million in share repurchases during this fiscal year and our new share repurchase program demonstrate our continued commitment to delivering long-term shareholder value,” said Steven H. Collis, AmerisourceBergen President & Chief Executive Officer.

AmerisourceBergen may repurchase its shares from time to time for cash in open market transactions or by other means in accordance with applicable federal securities laws. The Company currently has approximately 250.8 million common shares outstanding, and had previously said it expected to repurchase $500 million of its shares in fiscal 2012.

In addition, the Board of Directors today declared a cash dividend of $0.13 per share on Common Stock, payable June 4, 2012, to stockholders of record at the close of business on May 21, 2012.

About AmerisourceBergen

AmerisourceBergen is one of the world's largest pharmaceutical services companies serving the United States, Canada and selected global markets. Servicing both healthcare providers and pharmaceutical manufacturers in the pharmaceutical supply channel, the Company provides drug distribution and related services designed to reduce costs and improve patient outcomes. AmerisourceBergen's service solutions range from niche premium logistics and pharmaceutical packaging to reimbursement and pharmaceutical consulting services. With more than $80 billion in annual revenue, AmerisourceBergen is headquartered in Valley Forge, PA, and employs approximately 13,000 people. AmerisourceBergen is ranked #29 on the Fortune 500 list. For more information, go to www.amerisourcebergen.com.

Forward-Looking Statements

Certain of the statements contained in this press release are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.


Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.